Clinical Trials Directory

Trials / Terminated

TerminatedNCT02140788

Effects of Metformin and Fish Oil on Treatment With Clozapine

A Comparison Of The Effects Of Added Metformin (Versus No Added Metformin) On Psychopathology, Lipids, And Measures of Inflammation During The Initiation Or Re-Institution Of Treatment With Clozapine In Patients With Schizophrenia Or Schizoaffective Disorder

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
34 (actual)
Sponsor
Duke University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

One purpose of this study is to test whether adding metformin will limit some of the unwanted effects of clozapine, compared to not adding metformin. Metformin is a medication that is approved by the United States Food and Drug Administration (FDA) for the treatment of type-2 diabetes. Studies have found that people with type-2 diabetes often lose some weight when they take metformin, however the FDA has not approved metformin for weight loss, so for this study the use of metformin is investigational. This study will test whether metformin can help people with schizophrenia or schizoaffective disorders lose weight. Another purpose of this study is to test whether adding fish oil will improve the benefit of clozapine and/or limit some of the unwanted effects of clozapine, compared to not adding fish oil. Fish oil is a medication used to reduce levels of some fats (triglycerides) in blood. Some studies have found that adding fish oil reduces psychosis (voices, suspiciousness). However the FDA has not approved fish oil for reducing psychosis, so for this study the use of fish oil is investigational. This study will test whether fish oil can help people with schizophrenia or schizoaffective disorders have less psychosis. Fish oil is not an antipsychotic medication.

Conditions

Interventions

TypeNameDescription
DRUGMetformin
DRUGFish Oil

Timeline

Start date
2011-05-01
Primary completion
2013-02-01
Completion
2013-02-01
First posted
2014-05-16
Last updated
2023-10-26
Results posted
2014-11-14

Source: ClinicalTrials.gov record NCT02140788. Inclusion in this directory is not an endorsement.